Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
Metabolic Syndrome - Bacillota |
📓
Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults. Data in brief (Data Brief ) Vol: 34 Issue Pages: 106690 Pub: 2021 Feb Epub: 2020 Dec 24 Authors Hoang HT , Le DH , Le TTH , Nguyen TTN , Chu HH , Nguyen NT , Html Article Publication |
Metabolic Syndrome - Bacillota |
📓
Correlation between alterations of gut microbiota and miR-122-5p expression in patients with type 2 diabetes mellitus. Annals of translational medicine (Ann Transl Med ) Vol: 8 Issue 22 Pages: 1481 Pub: 2020 Nov Epub: Authors Li L , Li C , Lv M , Hu Q , Guo L , Xiong D , Html Article Publication |
Metabolic Syndrome - Bacillota |
📓
Implication of the gut microbiome composition of type 2 diabetic patients from northern China. Scientific reports (Sci Rep ) Vol: 10 Issue 1 Pages: 5450 Pub: 2020 Mar 25 Epub: 2020 Mar 25 Authors Li Q , Chang Y , Zhang K , Chen H , Tao S , Zhang Z , Html Article Publication |
Metabolic Syndrome - Bacillota |
📓
[The characteristics of gut microbiota in type 2 diabetes mellitus patients with hypertriglyceridemia]. Zhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi ) Vol: 102 Issue 47 Pages: 3763-3768 Pub: 2022 Dec 20 Epub: Authors Zhang Q , Hu WM , Deng YL , Long Q , Jin P , Publication |
Metabolic Syndrome - Bacillota |
📓
Gut Microbiota Dysbiosis Drives and Implies Novel Therapeutic Strategies for Diabetes Mellitus and Related Metabolic Diseases Frontiers in Immunology (Front Immunol ) Vol: 8 Issue Pages: 1882 Pub: 2017 Dec 20 Epub: 2017 Dec 20 Authors Li X , Watanabe K , Kimura I , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.